Market Overview:Rhu albumin refers to recombinant human albumin which is produced through recombinant DNA technology and not from human blood plasma. It finds various applications in medicine and pharmaceutical industry due to its properties such as maintaining colloid osmotic pressure in the bloodstream, transporting molecules like hormones, fatty acids and synthetic medicines. Key uses of rhu...
Recombinant human albumin (rHu Albumin) is a sterile, stable, and non-pyrogenic solution containing minimum 99% purified albumin. Albumin is the most abundant protein in human blood plasma and serves to regulate the colloidal osmotic pressure of blood and acts as a transport and reservoir protein. rHu Albumin finds numerous therapeutic applications such as in burns, shocks, hypovolemia,...
The Rhu Albumin Market is estimated to be valued at US$ 84.9 Mn in 2022 and is expected to exhibit a CAGR of 10% over the forecast period 2022 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Rhu albumin is a recombinant form of human serum albumin produced from yeast. It finds applications as a stabilizer in cell culture media formulations. Rhu...